Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / SPONSORED ADR
-
Number of holders
-
824
-
Total 13F shares, excl. options
-
284M
-
Shares change
-
+7.26M
-
Total reported value, excl. options
-
$10.3B
-
Value change
-
+$265M
-
Put/Call ratio
-
0.24
-
Number of buys
-
376
-
Number of sells
-
-331
-
Price
-
$36.25
Significant Holders of GSK plc - SPONSORED ADR (GSK) as of Q3 2023
929 filings reported holding GSK - GSK plc - SPONSORED ADR as of Q3 2023.
GSK plc - SPONSORED ADR (GSK) has 824 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 284M shares
.
Largest 10 shareholders include Dodge & Cox (69.3M shares), FMR LLC (18.1M shares), Fisher Asset Management, LLC (13.6M shares), PRICE T ROWE ASSOCIATES INC /MD/ (12.8M shares), JTC Employer Solutions Trustee Ltd (12.4M shares), PRIMECAP MANAGEMENT CO/CA/ (12.1M shares), Royal Bank of Canada (8.08M shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (7.8M shares), MORGAN STANLEY (7.55M shares), and STATE STREET CORP (7.06M shares).
This table shows the top 824 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.